AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2014
Jul 24, 2014
34501_dirs_2014-07-24_8e09844c-6eb9-470f-aba0-7692da3da08f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-03-28
Reporting Person: Chan Phillip P. (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-28 | Stock Option | $0.195 | A | 1750000 | Acquired | 2024-03-28 | Common Stock (1750000) | Direct |
Footnotes
F1: The options will become exercisable based on the achievement of certain milestones connected to the Company's operations, subject to approval by the Board of Directors.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 30
Regulatory Filings
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Regulatory Filings
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Regulatory Filings
2025
Oct 3
Regulatory Filings
2025
Sep 16